Coexpression of normal and mutated CD40 ligand with deletion of a putative RNA lariat branchpoint sequence in X-linked hyper-IgM syndrome

被引:12
作者
Zhu, XM [1 ]
Chung, I
O'Gorman, MR
Scholl, PR
机构
[1] Childrens Mem Hosp, Dis Pathogenesis Program, Childrens Mem Inst Educ & Res, Chicago, IL 60614 USA
[2] Childrens Mem Hosp, Div Immunol Rheumatol, Chicago, IL 60614 USA
[3] Northwestern Univ, Sch Med, Dept Pediat, Chicago, IL 60614 USA
关键词
hyper-IgM syndrome; CD40; ligand; RNA splicing;
D O I
10.1006/clim.2001.5022
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We describe a novel CD40 ligand (CD40L) splicing mutation in a patient with X-linked hyper-IgM syndrome (X-HIM) associated with alternate splicing of exon 3, resulting in the expression of both full-length and exon-3-skipped CD40L mRNA. The mutation is an 8-bp deletion 25 bp upstream of the intron 2/exon 3 junction which overlaps a putative RNA branchpoint, suggesting that it may impair RNA lariat formation. The exon-3-skipped CD40L transcript encodes a truncated protein (CD40L Delta E3) encompassing the cytoplasmic, transmembrane, and extracellular stalk domains, but lacking the CD40L receptor binding domain. CD40L Delta E3 protein expression was readily detectable in transfected Cos cells by immunofluorescence. In cells cotransfected with CD40L Delta E3 and wild-type CD40L, expression of CD40L Delta E3 did not inhibit the expression of wild-type CD40L monomers, but strongly inhibited staining by the conformationally sensitive anti-CD40L mAb 5c8, suggesting that CD40L Delta E3 acts in a dominant negative manner to inhibit the assembly of functional CD40L trimers. This mechanism may contribute to the pathophysiology of CD40L deficiency in X-HIM patients with leaky splice site mutations. (C) 2001 Academic Press.
引用
收藏
页码:334 / 339
页数:6
相关论文
共 21 条
[1]   Defective antigen-induced lymphocyte proliferation in the X-linked hyper-IgM syndrome [J].
Ameratunga, R ;
Lederman, HM ;
Sullivan, KE ;
Ochs, HD ;
Seyama, K ;
French, JK ;
Prestidge, R ;
Marbrook, J ;
Fanslow, WC ;
Winkelstein, JA .
JOURNAL OF PEDIATRICS, 1997, 131 (01) :147-150
[2]  
CALLARD RE, 1994, J IMMUNOL, V153, P3295
[3]  
Fanslow W C, 1994, Semin Immunol, V6, P267, DOI 10.1006/smim.1994.1035
[4]   CD154 variants associated with Hyper-IgM syndrome can form oligomers and trigger CD40-mediated signals [J].
Garber, E ;
Su, LH ;
Ehrenfels, B ;
Karpusas, M ;
Hsu, YM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (47) :33545-33550
[5]   The CD40 ligand - At the center of the immune universe? [J].
Grewal, IS ;
Flavell, RA .
IMMUNOLOGIC RESEARCH, 1997, 16 (01) :59-70
[6]  
Hayward AR, 1997, J IMMUNOL, V158, P977
[7]   BRANCH POINT SELECTION IN ALTERNATIVE SPLICING OF TROPOMYOSIN PRE-MESSENGER RNAS [J].
HELFMAN, DM ;
RICCI, WM .
NUCLEIC ACIDS RESEARCH, 1989, 17 (14) :5633-5650
[8]  
KRAWCZAK M, 1992, HUM GENET, V90, P41
[9]   An intronic mutation in a lariat branchpoint sequence is a direct cause of an inherited human disorder (fish-eye disease) [J].
Kuivenhoven, JA ;
Weibusch, H ;
Pritchard, PH ;
Funke, H ;
Benne, R ;
Assmann, G ;
Kastelein, JJP .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (02) :358-364
[10]   A rare branch-point mutation is associated with missplicing of fibrillin-2 in a large family with congenital contractural arachnodactyly [J].
Maslen, C ;
Babcock, D ;
Raghunath, M ;
Steinmann, B .
AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 60 (06) :1389-1398